News | August 01, 2024
Ajanta Pharma posts Q1 FY25 consolidated PAT at Rs. 245.77 Cr
Ajanta Pharma has reported total income of Rs. 1,171.39 crores during the period ended June 30, 2024
Ajanta Pharma has reported total income of Rs. 1,171.39 crores during the period ended June 30, 2024
Fredun Pharmaceuticals has reported total income of Rs. 78.81 crores during the period ended June 30, 2024
Themis Medicare has reported total income of Rs. 123.95 crores during the period ended June 30, 2024
Granules India has reported total income of Rs. 1181.92 crores during the period ended June 30, 2024
Pfizer Ltd. has reported total income of Rs. 604.70 crores during the period ended June 30, 2024
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
Glenmark Life Sciences has reported total income of Rs. 594.109 crores during the period ended June 30, 2024
Laurus Labs has reported total income of Rs. 1,197.42 crores during the period ended June 30, 2024
Thyrocare Technologies has reported total income of Rs. 160.53 crores during the period ended June 30, 2024
Torrent Pharmaceuticals has reported total income of Rs. 2,883 crores during the period ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
